These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9716290)

  • 1. Study of beta-lactam resistance in ceftazidime-resistant clinical isolates of Enterobacteriaceae.
    Bujdáková H; Lausová A; Jankovicová S; Prodinger WM; Kallová J; Milosovic P; Kettner M
    Int J Antimicrob Agents; 1998 May; 10(2):135-41. PubMed ID: 9716290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence and transferability of beta-lactam resistance in Enterobacteriaceae isolated in Children's University Hospital in Bratislava.
    Bujdáková H; Hanzen J; Jankovicová S; Klimácková J; Moravcíková M; Milosovic P; Michálková-Papajová D; Kallová J; Jakab A; Kettner M
    Folia Microbiol (Praha); 2001; 46(4):339-44. PubMed ID: 11830947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum and transferability of beta-lactam resistance in hospital strains of Enterobacter isolated in Bratislava and Innsbruck.
    Bujdáková H; Klimáková J; Allerberger F; Moravcíková M; Bagová M; Hanzen J; Michálková-Papajová D; Dierich MP; Kettner M
    Int J Antimicrob Agents; 2000 Sep; 16(1):31-6. PubMed ID: 10957579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.
    Jarlier V; Nicolas MH; Fournier G; Philippon A
    Rev Infect Dis; 1988; 10(4):867-78. PubMed ID: 3263690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of endemic plasmids causing beta-lactam resistance in Enterobacteriaceae in children's university hospital in Munich.
    Benczeová S; Adam D; Vrábelová M; Michálková-Papajová D; Kettner M
    Folia Microbiol (Praha); 2004; 49(4):457-64. PubMed ID: 15530013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae from Zagreb, Croatia.
    Bedenic B; Zagar Z
    J Chemother; 1998 Dec; 10(6):449-59. PubMed ID: 9876053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward.
    Hibbert-Rogers LC; Heritage J; Gascoyne-Binzi DM; Hawkey PM; Todd N; Lewis IJ; Bailey C
    J Antimicrob Chemother; 1995 Jul; 36(1):65-82. PubMed ID: 8537285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.
    López-Hernández I; Alonso N; Fernández-Martínez M; Zamorano L; Rivera A; Oliver A; Conejo MC; Martínez-Martínez L; Navarro F; Pascual A
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):499-504. PubMed ID: 27887765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and typing of extended-spectrum beta-lactamases in clinical isolates of the family Enterobacteriaceae in a medical center in Turkey.
    Durmaz R; Durmaz B; Koroglu M; Tekerekoglu MS
    Microb Drug Resist; 2001; 7(2):171-5. PubMed ID: 11442343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
    Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
    Jones RN; Salazar JC; Pfaller MA; Doern GV
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid-Mediated AmpC β-Lactamase and Underestimation of Extended-Spectrum β-Lactamase in Cefepime-Susceptible Elevated-Ceftazidime-MIC Enterobacteriaceae Isolates.
    Nishimura F; Morinaga Y; Akamatsu N; Matsuda J; Kaku N; Takeda K; Uno N; Kosai K; Hasegawa H; Yanagihara K
    Jpn J Infect Dis; 2018 Jul; 71(4):281-285. PubMed ID: 29709981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
    Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conjugative transfer frequency of resistance genes from ESBL-producing Enterobacteriaceae strains isolated from patients hospitalized in pediatric wards].
    Franiczek R; Dolna I; Krzyzanowska B; Szufnarowski K; Kowalska-Krochmal B; Zielińska M
    Med Dosw Mikrobiol; 2006; 58(1):41-51. PubMed ID: 16871972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
    Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J
    Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.